Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
BridgeBio Pharma, Inc. (BBIO) had Current Liabilities of $287.97M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$502.08M |
|
$-724.93M |
|
$20.96M |
|
$481.11M |
|
$1.03B |
|
$-523.41M |
|
$-209.09M |
|
$-732.50M |
|
$-732.50M |
|
$-732.94M |
|
$-732.94M |
|
$-732.94M |
|
$-732.94M |
|
$-523.41M |
|
$-512.01M |
|
191.53M |
|
191.53M |
|
$-3.78 |
|
$-3.78 |
|
| Balance Sheet Financials | |
$797.75M |
|
$5.37M |
|
$138.28M |
|
$936.02M |
|
|
Current Liabilities |
$287.97M |
$1.85B |
|
$2.72B |
|
$3.01B |
|
$-2.08B |
|
$-2.10B |
|
$-2.08B |
|
194.77M |
|
| Cash Flow Statement Financials | |
$-445.91M |
|
$-24.49M |
|
$359.29M |
|
$683.24M |
|
$572.14M |
|
$-111.10M |
|
$133.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.77 |
|
-- |
|
-- |
|
-8.29 |
|
-0.89 |
|
95.82% |
|
-104.25% |
|
-104.25% |
|
-101.98% |
|
-145.89% |
|
-144.39% |
|
$-447.01M |
|
-- |
|
-- |
|
-- |
|
0.54 |
|
0.78 |
|
3.60 |
|
101.37 |
|
35.31% |
|
34.83% |
|
-78.30% |
|
327.88% |
|
$-10.66 |
|
$-2.33 |
|
$-2.33 |
|